Work

A First-In-Human Clinical Trial of Adoptive Therapy Using CD19-Specific Chimeric Antigen Receptor Re-Directed T-Cells for Recurrent/Refractory Follicular Lymphoma.

Year: 2007

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v110.11.288.288

Authors: Michael C. Jensen, Leslie Popplewell, David DiGiusto, Michael Kalos, Andrew Raubitschek, Stephen J. Forman

Institutions: City Of Hope National Medical Center, City of Hope

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2580918267

FWCI: 3.012

Cites:

Cited by: 22

Related to: 10